Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein PET117 homolog, mitochondrial (PET117) is a small, highly conserved mitochondrial chaperone and assembly factor essential for the biogenesis of cytochrome c oxidase (Complex IV) in the mitochondrial respiratory chain[3][4][7]. PET117 works in concert with other chaperones such as PET100 and MR-1S to ensure the proper assembly and integration of both nuclear and mitochondrial-encoded subunits into a fully functional complex[3][4]. Loss-of-function mutations in PET117 can lead to isolated complex IV deficiency, resulting in mitochondrial disorders with neurological and systemic manifestations including neurodevelopmental regression, medulla oblongata lesions, and lactic acidosis[3][4]. Recent research has shown that PET117 also regulates the mitochondrial translation activator TACO1, stabilizing it and thereby supporting COX1 (complex IV subunit) synthesis and overall mitochondrial function[1]. PET117 itself, however, is not currently a recognized direct therapeutic target or receptor[7][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein PET117 homolog, mitochondrial (PET117).